Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) is a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon its expertise in novel tetracycline chemistry. The company’s leading product candidate, omadacycline, is the first in a new class of antibiotics derived from tetracyclines for use as a first-line monotherapy to treat serious bacterial infections […]

The state of Nevada is in high anticipation about its upcoming 2016 general election ballot initiative that proposes legalizing recreational use of marijuana. With Colorado’s $700 million wind-fall last year and trending to break $1 billion in annual revenues by 2016, the MMJ market in Nevada could very quickly get a whole lot bigger next […]

IGEN Networks Corp. (OTCQB: IGEN) invests in and manages businesses that deliver cloud-based services through machine-to-machine (M2M) device technologies for the protection and management of mobile assets and commercial fleets. By taking an active managerial role in these businesses, IGEN allows its technology subsidiaries to mitigate operational risk and realize revenue growth and capital appreciation. […]

Cytori Therapeutics, Inc. is a biotechnology company developing autologous cell therapies from adipose connective tissue designed to treat a variety of medical conditions. Since 2001, the company has leveraged its exploration of the massive treatment potential of adult adipose-derived stem and regenerative cells to position itself as a global leader in the emerging field of […]

Galaxy Gaming, Inc. (OTCQB: GLXZ) is a gaming company that’s engaged in the business of designing, manufacturing and acquiring proprietary casino table games and associated technology, platforms and systems for the global gaming industry. The company’s current base of products includes over 4,000 gaming tables located in more than 500 casinos, making it the world’s […]

Organovo Holdings, Inc. (NYSE MKT: ONVO) is an early commercial stage company focusing on the development and commercialization of functional human tissues for use in drug discovery and medical research. Utilizing its proprietary three-dimensional bioprinting technology, the company enables reproducible, automated creation of living human tissues that mimic the form and function of native tissues […]

Cleartronic is wrapping up the first half of 2015 with a flurry of activity. Earlier this month the company’s ReadyOp Communications subsidiary launched a project with a major retail corporation, and followed-up the news that its VoiceInterop, Inc. subsidiary had signed a deal with an airport in Alberta, Canada. As a technology holding company, Cleartronic […]

Governments and insurance companies around the world are seeking innovative technologies that address the needs of the growing diabetic population in over-burdened public and private healthcare systems. In the U.S. alone, the national cost of diabetes in 2012 was $245 billion, compared to $174 billion in 2007. LabStyle Innovations (OTCQB:DRIO) is answering this call with […]

Today, Galenfeha announced on its website that the company has brought on Chris W. Watkins as Senior Business Development Manager in its sales department. He joined Galenfeha on June 15, 2015. Mr. Watkins adds nearly three decades of sales and management experience in the oil and gas industry, including directing sales operations and managing distributors […]

Consorteum Holdings is taking center stage in the emerging market of mobile gaming through the continued development of its proprietary Universal Mobile Interface (UMI). This groundbreaking technology will open the door for significant savings during game development by creating a carrier, operating system and device agnostic platform upon which to build. The company’s system eliminates […]